COVID-19 大流行期间的全球肝细胞癌管理。
Worldwide management of hepatocellular carcinoma during the COVID-19 pandemic.
机构信息
Department of Interventional Radiology Unit, "F. Miulli" General Regional Hospital, Acquaviva delle Fonti 70021, Bari, Italy.
Unit of Hepato-Pancreatic-Biliary Surgery, "F. Miulli" General Regional Hospital, Acquaviva delle Fonti 70124, Bari, Italy.
出版信息
World J Gastroenterol. 2021 Jul 7;27(25):3780-3789. doi: 10.3748/wjg.v27.i25.3780.
The coronavirus disease 2019 (COVID-19) pandemic has impacted hospital organization, with the necessity to quickly react to face the pandemic. The management of the oncological patient has been modified by necessity due to different allocation of nurses and doctors, requiring new strategies to guarantee the correct assistance to the patients. Hepatocellular carcinoma, considered as one of the most aggressive types of liver cancer, has also required a different management during this period in order to optimize the management of patients at risk for and with this cancer. The aim of this document is to review recommendations on hepatocellular carcinoma surveillance and management, including surgery, liver transplantation, interventional radiology, oncology, and radiotherapy. Publications and guidelines from the main scientific societies worldwide regarding the management of hepatocellular carcinoma during the COVID-19 pandemic were reviewed.
2019 年冠状病毒病（COVID-19）大流行对医院组织产生了影响，需要迅速作出反应以应对这一大流行病。由于护士和医生的不同分配，必须对肿瘤患者的管理进行修改，这需要新的策略来保证为患者提供正确的帮助。肝细胞癌被认为是最具侵袭性的肝癌类型之一，在这期间也需要进行不同的管理，以便优化对有风险和患有这种癌症的患者的管理。本文的目的是回顾关于肝细胞癌监测和管理的建议，包括手术、肝移植、介入放射学、肿瘤学和放射治疗。回顾了全球主要科学学会关于 COVID-19 大流行期间肝细胞癌管理的出版物和指南。
Zotero 插件